Skip to main content
SpringerLink
Log in

Consensus report of the 2nd International Forum for Liver MRI

  • Published:
European Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ba–Ssalamah A, Uffmann M, Saini S, Bastati N, Herold C, Schima W (2009) Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 19:342–357

    Article  PubMed  Google Scholar 

  2. Reimer P, Schneider G, Schima W (2004) Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 14:559–578

    Article  PubMed  Google Scholar 

  3. Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H (1991) A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med 22:233–237

    Article  CAS  PubMed  Google Scholar 

  4. Hamm B, Staks T, Mühler A, Bollow M, Taupitz M, Frenzel T, Wolf KJ, Weinmann HJ, Lange L (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785–792

    CAS  PubMed  Google Scholar 

  5. Shuter B, Tofts PS, Wang SC, Pope JM (1996) The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat. Magn Reson Imaging 14:243–253

    Article  CAS  PubMed  Google Scholar 

  6. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40:715–724

    Article  PubMed  Google Scholar 

  7. Vander Elst L, Maton F, Laurent S, Seghi F, Chapelle F, Muller RN (1997) A multinuclear MR study of Gd-EOB-DTPA: comprehensive preclinical characterization of an organ-specific MRI contrast agent. Magn Reson Med 38:604–614

    Article  CAS  PubMed  Google Scholar 

  8. Murakami T, Kim T, Oi H, Nakamura H, Igarashi H, Matsushita M, Okamura J, Kozuka T (1995) Detectability of hypervascular hepatocellular carcinoma by arterial phase images of MR and spiral CT. Acta Radiol 36:372–376

    Article  CAS  PubMed  Google Scholar 

  9. Malone D, Zech CJ, Ayuso C, Bartolozzi C, Jonas E, Tanimoto A (2008) Magnetic resonance imaging of the liver: consensus statement of the 1st Primovist User Meeting. Eur Radiol Suppl 18:849–864

    Article  Google Scholar 

  10. Goudemant JF, Van Beers BE, Demeure R, Grandin C, Delos M, Pringot J (1998) Comparison of unenhanced and gadoxetate disodium-enhanced spin-echo magnetic resonance imaging for the detection of experimental hepatocellular carcinoma in the rat. Invest Radiol 33:80-84

    Article  CAS  PubMed  Google Scholar 

  11. Khangure MS, Hua J (1996) Comparative assessment of gadoxetate disodium, manganese dipyridoxal diphosphate, and superparamagnetic iron oxide for enhancement of the liver in dogs. Acad Radiol 3(Suppl 2):S458–S460

    Article  Google Scholar 

  12. Schmitz SA, Mühler A, Wagner S, Wolf KJ (1996) Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats. Invest Radiol 31:154–160

    Article  CAS  PubMed  Google Scholar 

  13. Segers J, Le Duc G, Laumonier C, Troprès I, Elst LV, Muller RN (2005) Evaluation of Gd-EOB-DTPA uptake in a perfused and isolated mouse liver model: correlation between magnetic resonance imaging and monochromatic quantitative computed tomography. Invest Radiol 40:574–582

    Article  CAS  PubMed  Google Scholar 

  14. Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, Casalino DD, Davis PL, Francis IR, Krinsky G, Lee FT Jr, Lu D, Paulson EK, Schwartz LH, Siegelman ES, Small WC, Weber TM, Welber A, Shamsi K (2005) Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase-III study. Radiology 237:89–98

    Article  PubMed  Google Scholar 

  15. Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB (2007) Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. Acta Radiol 48:362–368

    Article  PubMed  Google Scholar 

  16. Halavaara J, Breuer J, Ayuso C, Balzer T, Bellin MF, Blomqvist L, Carter R, Grazioli L, Hammerstingl R, Huppertz A, Jung G, Krause D, Laghi A, Leen E, Lupatelli L, Marsili L, Martin J, Pretorius ES, Reinhold C, Stiskal M, Stolpen AH (2006) Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT – a multicenter trial. J Comput Assist Tomogr 30:345–354

    Article  PubMed  Google Scholar 

  17. Hamm B, Thoeni RF, Gould RG, Bernardino ME, Lüning M, Saini S, Mahfouz AE, Taupitz M, Wolf KJ (1994) Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 190:417–423

    CAS  PubMed  Google Scholar 

  18. Hammerstingl R, Zangos S, Schwarz W, Rosen T, Bechstein WO, Balzer T, Vogl TJ (2002) Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient. Acad Radiol 9(Suppl 1):S119–S120

    Article  Google Scholar 

  19. Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz–Peer G, Laniado M, Manfredi RM, Mathieu DG, Mueller D, Reimer P, Robinson PJ, Strotzer M, Taupitz M, Vogl TJ; European EOB Study Group (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230:266–275

    Article  PubMed  Google Scholar 

  20. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, Helmberger TK, Reiser MF (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT – initial observations. Radiology 234:468–478

    Article  PubMed  Google Scholar 

  21. Kacl GM, Hagspiel KD, Marincek B (1997) Focal nodular hyperplasia of the liver: serial MRI with Gd-DOTA, superparamagnetic iron oxide, and Gd-EOB-DTPA. Abdom Imaging 22:264–267

    Article  CAS  PubMed  Google Scholar 

  22. Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, Hesse T, Berns T, Peters PE (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177–183

    CAS  PubMed  Google Scholar 

  23. Reimer P, Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tombach B, Peters PE (1997) Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 7:275–280

    Article  CAS  PubMed  Google Scholar 

  24. Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, Schwarz W, Müller PK, Bechstein WO, Mack MG, Söllner O, Felix R (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59–67

    CAS  PubMed  Google Scholar 

  25. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO (2007) MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 6:43–52

    Article  PubMed  Google Scholar 

  26. Hammerstingl R, Huppertz A, Breuer J, Balzer T, Blakeborough A, Carter R, Fusté LC, Heinz-Peer G, Judmaier W, Laniado M, Manfredi RM, Mathieu DG, Müller D, Mortelè K, Reimer P, Reiser MF, Robinson PJ, Shamsi K, Strotzer M, Taupitz M, Tombach B, Valeri G, van Beers BE, Vogl TJ; European EOB-study group (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 18:457–467

    Article  PubMed  Google Scholar 

  27. Bae KT, Heiken JP, Brink JA (1998) Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate–pharmacokinetic analysis and experimental porcine model. Radiology 206:455–464

    CAS  PubMed  Google Scholar 

  28. Prince MR (1994) Gadolinium-enhanced MR aortography. Radiology 191:155–164

    CAS  PubMed  Google Scholar 

  29. Shinozaki K, Yoshimitsu K, Irie H, Aibe H, Tajima T, Nishie A, Nakayama T, Kakihara D, Shimada M, Honda H (2004) Comparison of test-injection method and fixed-time method for depiction of hepatocellular carcinoma using dynamic steady-state free precession magnetic resonance imaging. J Comput Assist Tomogr 28:628–634

    Article  PubMed  Google Scholar 

  30. Foo TK, Saranathan M, Prince MR, Chenevert TL (1997) Automated detection of bolus arrival and initiation of data acquisition in fast, three-dimensional, gadolinium-enhanced MR angiography. Radiology 203:275–280

    CAS  PubMed  Google Scholar 

  31. Prince MR, Chenevert TL, Foo TK, Londy FJ, Ward JS, Maki JH (1997) Contrast-enhanced abdominal MR angiography: optimization of imaging delay time by automating the detection of contrast material arrival in the aorta. Radiology 203:109–114

    CAS  PubMed  Google Scholar 

  32. Ho VB, Foo TK (1998) Optimization of gadolinium–enhanced magnetic resonance angiography using an automated bolus-detection algorithm (MR SmartPrep). Original investigation. Invest Radiol 33:515–523

    Article  CAS  PubMed  Google Scholar 

  33. Riedy G, Golay X, Melhem ER (2005) Three-dimensional isotropic contrast-enhanced MR angiography of the carotid artery using sensitivity-encoding and random elliptic centric k-space filling: technique optimization. Neuroradiology 47:668–673

    Article  CAS  PubMed  Google Scholar 

  34. Svensson J, Petersson JS, Ståhlberg F, Larsson EM, Leander P, Olsson LE (1999) Image artefacts due to a time-varying contrast medium concentration in 3D contrast-enhanced MRA. Magn Reson Imaging 10:919–928

    Article  CAS  Google Scholar 

  35. Maki JH, Prince MR, Londy FJ, Chenevert TL (1996) The effects of time varying intravascular signal intensity and k-space acquisition order on three-dimensional MR angiography image quality. J Magn Reson Imaging 6:642–651

    Article  CAS  PubMed  Google Scholar 

  36. Carr JC, Nemcek AA Jr, Abecassis M, Blei A, Clarke L, Pereles FS, McCarthy R, Finn JP (2003) Preoperative evaluation of the entire hepatic vasculature in living liver donors with use of contrast-enhanced MR angiography and true fast imaging with steady-state precession. J Vasc Interv Radiol 14:441–44937

    PubMed  Google Scholar 

  37. Zech CJ, Vos B, Nordell A, Urich M, Blomqvist L, Breuer J, Reiser MF, Weinmann HJ (2009) Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA. Invest Radiol 44:305–310

    Article  CAS  PubMed  Google Scholar 

  38. Hany TF, McKinnon GC, Leung DA, Pfammatter T, Debatin JF (1997) Optimization of contrast timing for breath-hold three-dimensional MR angiography. J Magn Reson Imaging 7:551–556

    Article  CAS  PubMed  Google Scholar 

  39. Dorio PJ, Lee FT Jr, Henseler KP, Pilot M, Pozniak MA, Winter TC 3rd, Shock SA (2003) Using a saline chaser to decrease contrast media in abdominal CT. AJR Am J Roentgenol 180:929–934

    PubMed  Google Scholar 

  40. Haage P, Schmitz-Rode T, Hübner D, Piroth W, Günther RW (2000) Reduction of contrast material dose and artefacts by a saline flush using a double power injector in helical CT of the thorax. AJR Am J Roentgenol 174:1049–1053

    CAS  PubMed  Google Scholar 

  41. Orlandini F, Boini S, Iochum-Duchamps S, Batch T, Zhu X, Blum A (2005) Assessment of the use of a saline chaser to reduce the volume of contrast medium in abdominal CT. AJR Am J Roentgenol 187:511–515

    Article  Google Scholar 

  42. Saini, S; Nelson, RC (1995) Technique for MR imaging of the liver. Radiology 197:575–577

    CAS  PubMed  Google Scholar 

  43. Kim T, Murakami T, Hasuike Y, Gotoh M, Kato N, Takahashi M, Miyazawa T, Narumi Y, Monden M, Nakamura H (1997) Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imaging 7:683–688

    Article  CAS  PubMed  Google Scholar 

  44. Runge VM (1998) A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. J Comput Assist Tomogr 22:643–650

    Article  CAS  PubMed  Google Scholar 

  45. Tschirch FT, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D (2008) Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 18:1577–1586

    Article  PubMed  Google Scholar 

  46. Rofsky NM, Weinreb JC, Ambrosino MM, Safir J, Krinsky G (1996) Comparison between in-phase and opposed-phase T1-weighted breathhold FLASH sequences for hepatic imaging. J Comput Assist Tomogr 20:230–235

    Article  CAS  PubMed  Google Scholar 

  47. Namasivayam S, Martin DR, Saini S (2007) Imaging of liver metastases: MRI. Cancer Imaging 7:2–9

    Article  PubMed  Google Scholar 

  48. Tanimoto A, Yuasa Y, Jinzaki M, Nakatsuka S, Takeda T, Kurata T, Shinmoto H, Kuribayashi S (2002) Routine MR imaging protocol with breath-hold fast scans: diagnostic efficacy for focal liver lesions. Radiat Med 20:169–179

    PubMed  Google Scholar 

  49. Ramalho M, Altun E, Herédia V, Zapparoli M, Semelka R (2007) Liver MR imaging: 1.5T versus 3T. Magn Reson Imaging Clin N Am 15:321–347

    Article  PubMed  Google Scholar 

  50. Schindera ST, Merkle EM, Dale BM, Delong DM, Nelson RC (2006) Abdominal magnetic resonance imaging at 3.0 T. What is the ultimate gain in signal-to-noise ratio? Acad Radiol 13:1236–1243

    Article  PubMed  Google Scholar 

  51. von Falkenhausen MM, Lutterbey G, Morakkabati-Spitz N, Walter O, Gieseke J, Blömer R, Willinek WA, Schild HH, Kuhl CK (2006) High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T. Radiology 241:156–166

    Article  Google Scholar 

  52. Tsurusaki M, Semelka RC, Zapparoli M, Elias J Jr, Altun E, Pamuklar E, Sugimura K (2008) Quantitative and qualitative comparison of 3.0T and 1.5T MR imaging of the liver in patients with diffuse parenchymal liver disease. Eur J Radiol Sep 12

  53. Asbach P, Warmuth C, Stemmer A, Rief M, Huppertz A, Hamm B, Taupitz M, Klessen C (2008) High spatial resolution T1-weighted MR imaging of liver and biliary tract during uptake phase of a hepatocyte-specific contrast medium. Invest Radiol 43:809–915

    Article  PubMed  Google Scholar 

  54. Casarella WJ, Knowles DM, wolff M, Johnson PM (1978) Focal nodular hyperplasia and liver cell adenoma: radiologic and pathologic differentiation. AJR Am J Roentgenol 131:393–402

    CAS  PubMed  Google Scholar 

  55. Paradis V, Benzekri A, Dargère D, Bièche I, Laurendeau I, Vilgrain V, Belghiti J, Vidaud M, Degott C, Bedossa P (2004) Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126:1323–1329

    Article  PubMed  Google Scholar 

  56. Mortelé KJ, Praet M, Van Vlierberghe H, Kunnen M, Ros PR (2000) CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic–pathologic correlation. AJR Am J Roentgenol 175:687–692

    PubMed  Google Scholar 

  57. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO (2008) Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPAenhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 43:504–511

    Article  PubMed  Google Scholar 

  58. Giovagnoli O, Hein M, Terracciano L, Bongartz G, Ledermann HP (2008) MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients. AJR 190:W290-W293

    Article  Google Scholar 

  59. Grazioli L, Morana G, Kirchin MA, Schneider G. (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177

    Article  PubMed  Google Scholar 

  60. Oudkerk M, Torres CG, Song B, König M, Grimm J, Fernandez-Cuadrado J, Op de Beeck B, Marquardt M, van Dijk P, de Groot JC (2002) Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Radiology 223:517–524

    Article  PubMed  Google Scholar 

  61. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Takashima T, Nakanuma Y, Unoura M, Kobayashi K, Izumi R, Ida M, Kitagawa K (1991) Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 178:493–497

    CAS  PubMed  Google Scholar 

  62. Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Nonomura A, Nakanuma Y (1999) Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 172:969–976

    CAS  PubMed  Google Scholar 

  63. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Arai K, Gabata T, Takashima T, Nakanuma Y, Terada T, Ida M (1989) Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology 173:123–126

    CAS  PubMed  Google Scholar 

  64. Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, Murata M, Shibata K, Zushi S, Kurokawa M, Yonezawa T, Kawata S, Takamura M, Nagano H, Sakon M, Monden M, Wakasa K, Nakamura H (2000) Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32:205–212

    Article  CAS  PubMed  Google Scholar 

  65. Lim JH, Choi D, Cho SK, Kim SH, Lee WJ, Lim HK, Park CK, Paik SW, Kim YI (2001) Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220:669–676

    Article  CAS  PubMed  Google Scholar 

  66. Suzuki S, Iijima H, Moriyasu F, Sasaki S, Yanagisawa K, Miyahara T, Oguma K, Yoshida M, Horibe T, Ito N, Kakizaki D, Abe K, Tsuchiya K (2004) Differential diagnosis of hepatic nodules using delayed parenchymal phase imaging of Levovist contrast ultrasound: comparative study with SPIO-MRI. Hepatol Res 29:122–126

    Article  PubMed  Google Scholar 

  67. Lim JH, Lee SJ, Lee WJ, Lim HK, Choo SW, Choo IW (1999) Iodized oil retention due to postbiopsy arterioportal shunt: a false positive lesion in the investigation of hepatocellular carcinoma. Abdom Imaging 24:165–170

    Article  CAS  PubMed  Google Scholar 

  68. Peterson MS, Baron RL, Marsh JW Jr, Oliver JH 3rd, Confer SR, Hunt LE (2000) Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 217:743–749

    CAS  PubMed  Google Scholar 

  69. Kudo M, Okanoue T; Japan Society of Hepatology (2007) Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 72(Suppl 1):2–15

    Article  PubMed  Google Scholar 

  70. Roncalli M, Borzio M, Di Tommaso L (2008) Hepatocellular dysplastic nodules. Ann Ital Chir 79:81–89

    PubMed  Google Scholar 

  71. di Martino M, Marin D, Guerrisi A, Geiger D, Galati F, Catalano C (2008) Detection of hepatocellular carcinoma (HCC) in patients with cirrhosis: intraindividual comparison of gadoxetic acid (GD-EOB-DTPA)-enhanced MR imaging and multiphasic 64-slice CT [abstract ssa07-07]. Radiological Society of North America

  72. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J; EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma (2001). Conclusions of the Barcelona – 2000 EASL conference. J Hepatol 35:421–430

    Article  CAS  PubMed  Google Scholar 

  73. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236

    Article  PubMed  Google Scholar 

  74. Okita K (2006) Clinical aspects of hepatocellular carcinoma in Japan. Intern Med 45:229–233

    Article  PubMed  Google Scholar 

  75. Hori M, Murakami T, Oi H, Kim T, Takahashi S, Matsushita M, Tomoda K, Narumi Y, Kadowaki K, Nakamura H (1998) Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intraarterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium. Acta Radiol 39:144–151

    Article  CAS  PubMed  Google Scholar 

  76. Sontum PC (2008) Physicochemical characteristics of Sonazoid, a new contrast agent for ultrasound imaging. Ultrasound Med Biol 34:824–833

    Article  PubMed  Google Scholar 

  77. Hatanaka K, Kudo M, Minami Y, Ueda T, Tatsumi C, Kitai S, Takahashi S, Inoue T, Hagiwara S, Chung H, Ueshima K, Maekawa K (2008) Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 51(Suppl 1):61–69

    Article  PubMed  Google Scholar 

  78. Maruyama H, Takahashi M, Ishibashi H, Okugawa H, Okabe S, Yoshikawa M, Yokosuka O (2008) Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography. Liver Int Sep 18

  79. Luo W, Numata K, Morimoto M, Nozaki A, Nagano Y, Sugimori K, Zhou X, Tanaka K (2008) Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions. Eur J Radiol Oct 17

  80. di Martino M, Marin D, Guerrisi A, Geiger D, Catalano C, Passariello R (2009) Intraindividual comparison of gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and multiphasic 64-slice CT for the detection of hepatocellular carcinoma (HCC) in patients with cirrhosis [abstract B-096]. Proceedings of the European Congress of Radiology, Vienna, Austria

  81. Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192:1675–161

    Article  PubMed  Google Scholar 

  82. Harris JP, Nelson RC (2004) Abdominal Imaging with multidetector computed tomography: State of the art. J Comput Assist Tomogr 28(Suppl 1):S17–S19

    Article  Google Scholar 

  83. Leoni S, Piscaglia F, Righini R, Bolondi L (2006) Management of small hepatocellular carcinoma. Acta Gastroenterol Belg 69:230–235

    CAS  PubMed  Google Scholar 

  84. Ridgway PE, Darzi AW (2003) The role of total mesorectal excision in the management of rectal cancer. Cancer Control 10:205–211

    PubMed  Google Scholar 

  85. Engelen SM, Beets GL, Beets-Tan RG (2007) Role of preoperative local and distant staging in rectal cancer. Onkologie 30:141–145

    Article  PubMed  Google Scholar 

  86. Beets-Tan RG, Beets GL, Vliegen RF, Kessels AG, Van Boven H, De Bruine A, von Meyenfeldt MF, Baeten CG, van Engelshoven JM (2001) Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357:497–504

    Article  CAS  PubMed  Google Scholar 

  87. Oberholzer K, Junginger T, Kreitner KF, Krummenauer F, Simiantonaki N, Trouet S, Thelen M (2005) Local staging of rectal carcinoma and assessment of the circumferential resection margin with high–resolution MRI using an integrated parallel acquisition technique. J Magn Reson Imaging 22:101–108

    Article  PubMed  Google Scholar 

  88. Mühler A, Clément O, Vexler V, Berthezène Y, Rosenau W, Brasch RC (1992) Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases. Radiology 184:207–213

    PubMed  Google Scholar 

  89. Stern W, Schick F, Kopp AF, Reimer P, Shamsi K, Claussen CD, Laniado M (2000) Dynamic MR imaging of liver metastases with Gd-EOB-DTPA. Acta Radiol 41:255–262

    Article  CAS  PubMed  Google Scholar 

  90. Ferris JV, Marsh JW, Little AF (1995) Presurgical evaluation of the liver transplant candidate. Radiol Clin North Am 33:497–520

    CAS  PubMed  Google Scholar 

  91. Rosenbaum SJ, Stergar H, Antoch G, Veit P, Bockisch A, Kühl H (2006) Staging and follow-up of gastrointestinal tumors with PET/CT. Abdom Imaging 31:25–35

    Article  CAS  PubMed  Google Scholar 

  92. Mang T, Graser A, Schima W, Maier A (2007) CT colonography: techniques, indications, findings. Eur J Radiol 61:388–399

    Article  PubMed  Google Scholar 

  93. Tunaci M (2004) Multidetector row CT of the pancreas. Eur J Radiol 52:18–30

    Article  PubMed  Google Scholar 

  94. Freelove R, Walling AD (2006) Pancreatic cancer: diagnosis and management. Am Fam Physician 73:485–492

    PubMed  Google Scholar 

  95. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT (2007) Imaging prostate cancer: a multidisciplinary perspective. Radiology 243:28–53

    Article  PubMed  Google Scholar 

  96. Glick SJ (2007) Breast CT. Annu Rev Biomed Eng 9:501–526

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan

    Akihiro Tanimoto

  2. Department of Radiology, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul, 110-744, Korea

    Jeong Min Lee

  3. Department of Radiology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan

    Takamichi Murakami

  4. Imaging Science Institute Charité, Berlin, Robert-Koch-Platz 7, 10115, Berlin, Germany

    Alexander Huppertz

  5. Department of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan

    Masatoshi Kudo

  6. Department of Radiology, Civic Hospital of Brescia, University of Brescia, Piazzale Spedali Civili I, 25023, Brescia, Italy

    Luigi Grazioli

Authors
  1. Akihiro Tanimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeong Min Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takamichi Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexander Huppertz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masatoshi Kudo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luigi Grazioli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanimoto, A., Min Lee, J., Murakami, T. et al. Consensus report of the 2nd International Forum for Liver MRI. Eur Radiol 19 (Suppl 5), 975 (2009). https://doi.org/10.1007/s00330-009-1624-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s00330-009-1624-y

Search

Navigation